Advanced Cell Therapy Centre
Our Advanced Cell Therapy Centre manufactures, researches and develops new cell therapy products for use in healthcare. Between 2013 and 2022, a total of over 120 patients received experimental cell therapy products and tissue products manufactured by the Blood Service.
In 2022, we manufactured products such as mesenchymal stromal cell products (LY-MSC) for the treatment of immunological problems due to blood stem cell grafts as well modified haploidentical stem cell grafts for the treatment of paediatric patients. Together with pharmaceutical companies, we also improved our manufacturing capacity for CAR T-cell products used in the treatment of cancers.
Our new cleanroom unit was completed in the new headquarters in Vehkala. The three separate cleanrooms will significantly improve our ability to develop and manufacture new products.